Iniziativa
One year treatment of Saxagliptin/Dapagliflozin + Metformin vs insulin glargine + metformin in subjects with Latent Autoimmune type 1 Diabetes in Adults (LADA): the “LADASaxaDapa” study
Referente attività: Buzzetti Raffaella, Maddaloni Ernesto
Area di intervento: SALUTE PUBBLICA E BENESSERE
Durata dell’iniziativa: 2024
One year treatment of Saxagliptin/Dapagliflozin + Metformin vs insulin glargine + metformin in subjects with Latent Autoimmune type 1 Diabetes in Adults (LADA): the “LADASaxaDapa” study